DETECTion of PeriOperative Atrial Fibrillation After Noncardiac Surgery

(DETECT-POAF Trial)

Recruiting at 6 trial locations

Overseen By Kate Brady

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: Population Health Research Institute

Must not be taking: Anticoagulants, Antiplatelets

Disqualifiers: Chronic AF, Severe renal insufficiency, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

750 Participants Needed

What You Need to Know Before You Apply

What is the purpose of this trial?

This is a multicentre prospective cohort study where patients will receive up to 14 days of continuous ECG monitoring by wearing a portable monitoring device, starting within 72 hours after noncardiac surgery.

Who Is on the Research Team?

David Conen, MD, MPH

Principal Investigator

Population Health Research Institute

Michael K Wang, MD

Principal Investigator

Population Health Research Institute

Are You a Good Fit for This Trial?

Inclusion Criteria

I stayed in the hospital overnight after surgery.

I am having a major surgery that is not minor or under local anesthesia only.

I meet one of the high-risk criteria.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Monitoring

Participants receive up to 14 days of continuous ECG monitoring starting within 72 hours after noncardiac surgery

2 weeks

Continuous monitoring

Follow-up

Participants are monitored for safety and effectiveness after monitoring period

3 weeks

What Are the Treatments Tested in This Trial?

How Is the Trial Designed?

Group I: Study Cohort Experimental Treatment 1 Intervention

Participants will receive up to 14 days of continuous cardiac monitoring

Who Is Running the Clinical Trial?

Population Health Research Institute

Lead Sponsor

Trials

165

Recruited

717,000+